Chalfonts and Gerrards Cross Hospital

Recent papers from Chalfonts and Gerrards Cross Hospital

1. Global Socioeconomic Context and Brain Ageing in Epilepsy: an ENIGMA-Epilepsy study2026
2. Functional Neurological Disorder, Sleep, and Dreaming: A Large Online Questionnaire–Based StudyJournal of Neuropsychiatry · 2025
3. Magnetisation Transfer 3D-Radial Zero Echo Time MR Imaging at 7TJournal of Clinical Medicine · 2025
4. Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitor2025
5. Quantitative Cortex‐Based Mapping With Hybrid ¹⁸ F‐ FDG ‐ PET / MR Images in MRI ‐Negative EpilepsyCNS Neuroscience & Therapeutics · 2025
6. Practice of standard Cross Infection Protocol in Private Dental Clinics of Khyber Pakhtunkhwa, Pakistan: A cross-sectional studyJournal of Rawalpindi Medical College · 2022
7. Risk factors and outcome of hyperammonaemia in people with epilepsyJournal of Neurology · 2022
8. Differentially Expressed miRNAs in Age-Related Neurodegenerative Diseases: A Meta-AnalysisGenes · 2022
9. Green Health in Guatemala: How can we build mutual trust and partnerships to develop an evidence-base for local medicines and realize their potential?Botany · 2021
10. The geoscience profession's response to COVID-19 pandemic - An European Federation of Geologists' overviewEpisodes · 2021
11. Cerebral venous sinus thrombosis (CVST) is not significantly linked to COVID-19 vaccines or non-COVID vaccines in a large multi-state US health system2021
12. Increased facial asymmetry in focal epilepsies associated with unilateral lesionsBrain Communications · 2021
13. Chloroquine and hydroxychloroquine for COVID‐19: Perspectives on their failure in repurposingJournal of Clinical Pharmacy and Therapeutics · 2020
14. Thoughts aboutMycoplasma hominisSexually Transmitted Infections · 2020
15. Genotype‐guided warfarin therapy: Still of only questionable value two decades onJournal of Clinical Pharmacy and Therapeutics · 2020
16. White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA Epilepsy study2019
17. Safety of Novel Targeted Therapies in OncologyDrug Safety · 2019
18. Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges aheadJournal of Clinical Pharmacy and Therapeutics · 2018
19. Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualtyTherapeutic Advances in Drug Safety · 2018
20. Neuroimaging in epilepsyCurrent Opinion in Neurology · 2018